Roopal Thakkar Abb Vie Inc. (ABBV) insider trading activity

ABBV Quotes by TradingView

Roopal Thakkar is EVP, R&D and CSO of AbbVie Inc.. Currently has a direct ownership of 46,954 shares of ABBV, which is worth approximately $9.49 Million. The most recent transaction as insider was on Feb 13, 2025, when has been sold 10,555 shares (Common Stock, $0.01 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47K
101.87% 3M change
66.66% 12M change
Total Value Held $9.49 Million

Roopal Thakkar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2025
BUY
Grant, award, or other acquisition
-
10,555 Added 18.35%
46,954 Common Stock, $0.01 pa...
Feb 28 2024
SELL
Payment of exercise price or tax liability
$879,556 $178.99 p/Share
4,914 Reduced 17.44%
23,259 Common Stock, $0.01 pa...
Feb 15 2024
BUY
Grant, award, or other acquisition
-
17,796 Added 38.71%
28,173 Common Stock, $0.01 pa...
RT

Roopal Thakkar

EVP, R&D and CSO
North Chicago, IL

Track Institutional and Insider Activities on ABBV

Follow AbbVie Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABBV shares.

Notify only if

Insider Trading

Get notified when an Abb Vie Inc. insider buys or sells ABBV shares.

Notify only if

News

Receive news related to AbbVie Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABBV